A new option of reconstruction after extensive chest wall resection
In the present study, the first to assess Vitagraft® in chest wall reconstruction, the second operation was necessary for 28 %, and removal was mandatory for 14 %. Until now, chest postoperative tomography has been showing good prosthesis biocompatibility. The authors need further details about the ossification time especially relating to the size of the resection.
Authors
- João Gabriel Figuêredo de Macêdo
- José Ribas Milanez de Campos (ORCID: https://orcid.org/0000-0002-2385-7707)
- Pedro Henrique Xavier Nabuco de Araújo (ORCID: https://orcid.org/0000-0003-0817-8180)
- Ricardo Mingarini Terra (ORCID: https://orcid.org/0000-0001-8577-8708)
- Paulo Manuel Pêgo‐Fernandes (ORCID: https://orcid.org/0000-0001-7243-5343)
Institutions
- Instituto do Câncer do Estado de São Paulo (BR)
- Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (BR)
Publication Details
- Journal
- Clinics
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1016/j.clinsp.2025.100679
- Primary Topic
- Surgical site infection prevention
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Muscular Dystrophy Canada